wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCB
Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCB
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.
P2860
Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36462972-CC1B715B-07A5-4A4C-9BE0-4AE3A0054FCB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d2f3b9e898d0a5a58e9575217883d9a878fe620
P2860
Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.